Search research articles
Contact Us
Filters
Showing results (481-490 of 588) with videos related to
Page
of 59
Sort By:
Diabetes, Obesity & Metabolism
|
February 24, 2017
Comparative effectiveness and safety of different basal insulins in a real-world setting
Linong Ji, Puhong Zhang, Dongshan Zhu, et al.
Journal of Diabetes Investigation
|
August 7, 2018
Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study
Xiang Li, Zhangrong Xu, Linong Ji, et al.
BMJ Open Diabetes Research & Care
|
May 4, 2021
Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
Brenda Bongaerts, Suzanne V Arnold, Bernard H Charbonnel, et al.
Journal of Diabetes
|
October 29, 2014
Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence
Yuying Zhang, Rose Zw Ting, Wenying Yang, et al.
Diabetes, Obesity & Metabolism
|
November 26, 2022
Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
Leili Gao, Zhifeng Cheng, Benli Su, et al.
Frontiers in Endocrinology
|
November 12, 2021
Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population
Siqian Gong, Xueyao Han, Meng Li, et al.
Diabetes, Obesity & Metabolism
|
August 18, 2017
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany
Kamlesh Khunti, Thomas R Godec, Jesús Medina, et al.
Science China. Life Sciences
|
March 9, 2017
Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial
Wen Xu, Yiming Mu, Jiajun Zhao, et al.
Scientific Reports
|
June 5, 2023
The genetic and clinical characteristics of WFS1 related diabetes in Chinese early onset type 2 diabetes
Yating Li, Siqian Gong, Meng Li, et al.
Diabetes Research and Clinical Practice
|
March 25, 2019
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study
Marilia B Gomes, Wolfgang Rathmann, Bernard Charbonnel, et al.
Page
of 59
Search research articles
Search
Showing results (481-490 of 588) with videos related to
Sort By:
Page
of 59
Diabetes, Obesity & Metabolism
|
February 24, 2017
Comparative effectiveness and safety of different basal insulins in a real-world setting
Linong Ji, Puhong Zhang, Dongshan Zhu, et al.
Journal of Diabetes Investigation
|
August 7, 2018
Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study
Xiang Li, Zhangrong Xu, Linong Ji, et al.
BMJ Open Diabetes Research & Care
|
May 4, 2021
Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
Brenda Bongaerts, Suzanne V Arnold, Bernard H Charbonnel, et al.
Journal of Diabetes
|
October 29, 2014
Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence
Yuying Zhang, Rose Zw Ting, Wenying Yang, et al.
Diabetes, Obesity & Metabolism
|
November 26, 2022
Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
Leili Gao, Zhifeng Cheng, Benli Su, et al.
Frontiers in Endocrinology
|
November 12, 2021
Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population
Siqian Gong, Xueyao Han, Meng Li, et al.
Diabetes, Obesity & Metabolism
|
August 18, 2017
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany
Kamlesh Khunti, Thomas R Godec, Jesús Medina, et al.
Science China. Life Sciences
|
March 9, 2017
Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial
Wen Xu, Yiming Mu, Jiajun Zhao, et al.
Scientific Reports
|
June 5, 2023
The genetic and clinical characteristics of WFS1 related diabetes in Chinese early onset type 2 diabetes
Yating Li, Siqian Gong, Meng Li, et al.
Diabetes Research and Clinical Practice
|
March 25, 2019
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study
Marilia B Gomes, Wolfgang Rathmann, Bernard Charbonnel, et al.
Page
of 59